Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Boccellato group

DR. Francesco Boccellato

Our group is interested in oncogenic pathogens and in understanding their contribution to carcinogenesis. Patients infected with those pathogens have a higher chance of developing cancer, but the malignancy arises many years after the initial infection event. Cancer may develop as a result of a long battle between the pathogen that persists, hides and damages the tissue, and the host that attacks the pathogen and continuously repairs the damage caused by the infection. The epithelia of our body are strong defensive barriers that protect against infections. When an infection damages the tissue, this starts a regenerative program to maintain barrier integrity. However, the epithelium also experiences genomic instability as a result of the infection. We believe that regeneration and DNA damage are two crucial aspects of carcinogenesis. We use innovative tissue culture systems of human primary cells to re-build the infection niche in vitro and to understand the long term effect of infection on epithelial cells.  

Find out more about research in the Boccellato lab

Our team